Stratified psychiatry: Tomorrow's precision psychiatry?

Martijn Arns; Hanneke van Dijk; Jurjen J Luykx; Guido van Wingen; Sebastian Olbrich

doi:10.1016/j.euroneuro.2021.10.863

Stratified psychiatry: Tomorrow's precision psychiatry?

Martijn Arns^*
, Hanneke van Dijk
, Jurjen J Luykx
, Guido van Wingen
, Sebastian Olbrich

^*Corresponding author for this work

Neuroplasticity, Synchrony & Cognition

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Here we review the paradigm-change from one-size-fits-all psychiatry to more personalized-psychiatry, where we distinguish between 'precision psychiatry' and 'stratified psychiatry'. Using examples in Depression and ADHD we argue that stratified psychiatry, using biomarkers to facilitate patients to best 'on-label' treatments, is a more realistic future for implementing biomarkers in clinical practice.

Original language	English
Pages (from-to)	14-19
Number of pages	6
Journal	European Neuropsychopharmacology
Volume	55
Early online date	9 Nov 2021
DOIs	https://doi.org/10.1016/j.euroneuro.2021.10.863
Publication status	Published - Feb 2022

Keywords

ADHD
ASYMMETRY
Biomarker
DEPRESSION
Depression
EEG
Precision psychiatry
Stratified psychiatry

Access to Document

10.1016/j.euroneuro.2021.10.863Licence: CC BY

Cite this

@article{a54409eeaacd45569fd9fa11866d2d8b,

title = "Stratified psychiatry: Tomorrow's precision psychiatry?",

abstract = "Here we review the paradigm-change from one-size-fits-all psychiatry to more personalized-psychiatry, where we distinguish between 'precision psychiatry' and 'stratified psychiatry'. Using examples in Depression and ADHD we argue that stratified psychiatry, using biomarkers to facilitate patients to best 'on-label' treatments, is a more realistic future for implementing biomarkers in clinical practice.",

keywords = "ADHD, ASYMMETRY, Biomarker, DEPRESSION, Depression, EEG, Precision psychiatry, Stratified psychiatry",

author = "Martijn Arns and \{van Dijk\}, Hanneke and Luykx, \{Jurjen J\} and \{van Wingen\}, Guido and Sebastian Olbrich",

note = "Copyright {\textcopyright} 2021. Published by Elsevier B.V.",

year = "2022",

month = feb,

doi = "10.1016/j.euroneuro.2021.10.863",

language = "English",

volume = "55",

pages = "14--19",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Stratified psychiatry

T2 - Tomorrow's precision psychiatry?

AU - Arns, Martijn

AU - van Dijk, Hanneke

AU - Luykx, Jurjen J

AU - van Wingen, Guido

AU - Olbrich, Sebastian

PY - 2022/2

Y1 - 2022/2

N2 - Here we review the paradigm-change from one-size-fits-all psychiatry to more personalized-psychiatry, where we distinguish between 'precision psychiatry' and 'stratified psychiatry'. Using examples in Depression and ADHD we argue that stratified psychiatry, using biomarkers to facilitate patients to best 'on-label' treatments, is a more realistic future for implementing biomarkers in clinical practice.

AB - Here we review the paradigm-change from one-size-fits-all psychiatry to more personalized-psychiatry, where we distinguish between 'precision psychiatry' and 'stratified psychiatry'. Using examples in Depression and ADHD we argue that stratified psychiatry, using biomarkers to facilitate patients to best 'on-label' treatments, is a more realistic future for implementing biomarkers in clinical practice.

KW - ADHD

KW - ASYMMETRY

KW - Biomarker

KW - DEPRESSION

KW - Depression

KW - EEG

KW - Precision psychiatry

KW - Stratified psychiatry

U2 - 10.1016/j.euroneuro.2021.10.863

DO - 10.1016/j.euroneuro.2021.10.863

M3 - Article

C2 - 34768212

SN - 0924-977X

VL - 55

SP - 14

EP - 19

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -

Stratified psychiatry: Tomorrow's precision psychiatry?

Abstract

Keywords

Access to Document

Fingerprint

Cite this